Prostate cancer is one of the most common cancers affecting men worldwide. In recent years, advanced hormone-targeting medicines such as Enzalutamide and Abiraterone have significantly improved treatment outcomes for patients with advanced and metastatic prostate cancer. While both medicines target the androgen (male hormone) pathway that fuels prostate cancer growth, they work differently and may be suitable for different patients.
Enzalutamide vs Abiraterone Comparison
| Feature | Enzalutamide | Abiraterone |
|---|---|---|
| Mechanism | Blocks androgen receptors | Blocks androgen production |
| Steroid Required | No | Yes (Prednisone) |
| Administration | Once daily | Once daily |
| Cardiovascular Concerns | Moderate | Higher monitoring required |
| Liver Monitoring | Less frequent | More important |
| Generic Availability | Increasing | Widely available |
| Cost | Generally higher | Usually lower |
Which One Is Better Enzalutamide or Abiraterone?
There is no single “best” option for every patient. The choice depends on several factors:
Enzalutamide may be preferred when:
- A patient wants to avoid long-term steroid use.
- Blood sugar control is a concern.
- Fluid retention or cardiovascular risks are present.
Abiraterone may be preferred when:
- Cost is a major consideration.
- The patient tolerates prednisone well.
- The treating oncologist recommends hormone-production suppression as the preferred strategy.
Clinical studies suggest that both medicines provide substantial survival benefits, and treatment decisions should be individualized based on medical history, disease stage, side-effect profile, and physician recommendation.
Side Effects
Abiraterone’s side effects stem from hormonal disruption — it causes high blood pressure, fluid retention, and low potassium due to its CYP17A1 blocking mechanism, requiring concurrent prednisone. Enzalutamide carries a higher risk of fatigue compared to Abiraterone, though no significant difference was found between the two groups in terms of cognitive impairments.
Cost of Enzalutamide and Abiraterone in the Philippines
The price of prostate cancer medicines in the Philippines varies depending on the brand, dosage strength, importer, and pharmacy.
Enzalutamide Cost in the Philippines
- Branded versions are often expensive.
- Generic Enzalutamide options may offer significant savings compared with branded products.
Abiraterone Cost in the Philippines
- Generic Abiraterone is generally more affordable than Enzalutamide.
- Many patients choose generic versions due to lower treatment costs.
Patients are encouraged to compare prices from licensed suppliers and oncology pharmacies before purchasing.
What Is the New Treatment for Prostate Cancer in 2026?
For 2026, the biggest advancements in prostate cancer treatment are focused on radioligand therapies (RLTs), precision medicine, and treatment intensification before surgery, moving away from a one-size-fits-all approach.
Where Can You Buy Enzalutamide or Abiraterone in the Philippines?
Patients in the Philippines can obtain Enzalutamide and Abiraterone through licensed oncology pharmacies, hospital pharmacies, and international medicine suppliers that provide delivery services across major cities including Manila, Quezon City, Cebu City, Davao City, Makati, and other regions.
For patients seeking affordable generic Enzalutamide or Abiraterone options, it is important to purchase only from reputable and licensed suppliers and to consult an oncologist before starting or changing treatment.